![Paul Anthony Porter](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Paul Anthony Porter
Direktor/Vorstandsmitglied bei Valo Therapeutics Oy
Ursprung des Netzwerks ersten Grades von Paul Anthony Porter
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Valo Therapeutics Oy
![]() Valo Therapeutics Oy Pharmaceuticals: MajorHealth Technology Valo Therapeutics Oy is an immunotherapy company based in Helsinki, FI. The Finnish company is focused on developing innovative immunotherapy approaches against cancer and infectious disease. Valo Therapeutics's lead platform, PeptiCRAd, was developed out of the laboratory of Professor Vincenzo Cerullo at the University of Helsinki. The company is also developing PeptiEnv and PeptiVax, among other neoantigen strategies, in collaboration with Professor Cerullo. The company's PeptiChip technology enables the rapid and accurate identification of tumor antigens. Valo Therapeutics is also developing antigen-coated oncolytic viruses as anti-cancer therapeutic vaccines. The company was founded in 2016, and Paul Grant Higham has been the CEO of the company since 2020.
8
| Holding Company | Pharmaceuticals: Major | 8 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Paul Anthony Porter
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Charles River Discovery Research Services Finland Oy
![]() Charles River Discovery Research Services Finland Oy Miscellaneous Commercial ServicesCommercial Services Charles River Discovery Research Services Finland Oy provides non-clinical central nervous system services to the pharmaceutical and biotechnology industries. The company was founded in 1998 and is located in Kuopio, Finland. | Miscellaneous Commercial Services | Chief Executive Officer | |
Royal Perth Yacht Club | Director/Board Member | ||
Glycotope GmbH
![]() Glycotope GmbH BiotechnologyHealth Technology Glycotope GmbH operates as a biotechnology company to develop pharmaceutical therapeutics and nutrition additives. It focuses on the optimization and humanization of therapeutically relevant sugar structures on biopharmaceuticals known as glycosylation and on the development of innovative antibodies targeting glycostructures on cell surfaces. The company was founded by Steffen Goletz and Andreas Eckert in Febraury 2001 and is headquartered in Berlin, Germany. | Biotechnology | Chief Executive Officer | |
Bayer Pharmaceuticals Corp. | Corporate Officer/Principal | ||
BAYER AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
Immatics Biotechnologies GmbH
![]() Immatics Biotechnologies GmbH Pharmaceuticals: MajorHealth Technology Immatics Biotechnologies GmbH operates as a biopharmaceutical company that develops anti-cancer immunotherapy products. The firm specializes in the discovery and development of immunotherapy products against cancer. It develops IMA901, a combination of multiple tumor-associated peptides (TUMAPs) for the treatment of renal cell carcinoma. The company was founded by Harpreet Singh, Toni Weinschenk, Niels Emmerich, Hans Georg Rammensee, Hansjörg Schild, and Peter Brossart in 2000 and is headquartered in Tübingen, Germany. | Pharmaceuticals: Major | Chief Executive Officer | |
The Australia Day Council WA, Inc. | Director/Board Member | ||
Targovax Oy
![]() Targovax Oy Pharmaceuticals: MajorHealth Technology Targovax Oy focuses on the development and commercialization of targeted cancer immunotherapy. It is a biotechnology company with novel immunotherapy platform that is based on engineered oncolytic viruses armed with potent immune-stimulating transgenes. The firm's products induce a tailored response by the immune system directed at each patient’s unique cancer cells. The company was founded by Pekka Ilmari Simula and Antti Vuolanto in 2009 and is headquartered in Helsinki, Finland. | Pharmaceuticals: Major | Founder | |
HERAMED LIMITED | Packaged Software | Director/Board Member | |
EMPIRED LIMITED | Miscellaneous Commercial Services | Director of Finance/CFO | |
Governance Institute of Australia Ltd.
![]() Governance Institute of Australia Ltd. Miscellaneous Commercial ServicesCommercial Services Governance Institute of Australia Ltd. provides education, support, and networking opportunities for directors, Australian company secretaries, governance advisers, and risk managers. The private company is based in Sydney, Australia. Megan Motto has been the CEO of the company since 2019. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
ELDERS LIMITED | Agricultural Commodities/Milling | Comptroller/Controller/Auditor | |
AMCOM TELECOMMUNICATIONS LIMITED | Specialty Telecommunications | Director of Finance/CFO | |
IP Finland Oy
![]() IP Finland Oy Miscellaneous Commercial ServicesCommercial Services IP Finland Oy provides research and development services. It specializes in the commercialization of research-based intellectual property. The company is headquartered in Helsinki, Finland. | Miscellaneous Commercial Services | Director/Board Member | |
Valo Therapeutics Ltd. | Chief Executive Officer | ||
Medicel Oy
![]() Medicel Oy Information Technology ServicesTechnology Services Medicel Oy develops and provides software services for reverse engineering and modeling of biochemical pathways for drug discovery and validation. The company's product platforms include Medicel Integrator, Medicel Explorer, and Medicel Services. Medicel was founded in March 2001 and is headquartered in Espoo, Finland | Information Technology Services | Corporate Officer/Principal | |
University of Helsinki | College/University | Graduate Degree | |
Copenhagen University Hospital | College/University | Corporate Officer/Principal | |
Dansk Biotek
![]() Dansk Biotek Miscellaneous Commercial ServicesCommercial Services Dansk Biotek is an industry association for biotech companies with promoting the biotechnological research, development and production in taking care of corporate interests in this regard, both nationally and internationally. The company was founded in 1987 and is headquartered in Copenhagen, Denmark. | Miscellaneous Commercial Services | Director/Board Member | |
IO Biotech ApS
![]() IO Biotech ApS BiotechnologyHealth Technology IO Biotech ApS operates as a clinical stage biotech company. It develops immunotherapy for cancer by targeting a mechanism used by tumour cells to evade immune responses. The company was founded by Mai-Britt Zocca, Mads Hald Andersen, Inge Marie Svane, Anders Ljungqvist and Per Thor Straten and is headquartered in Copenhagen, Denmark. | Biotechnology | Chief Executive Officer | |
Entrepreneurial Learning Lab | Corporate Officer/Principal | ||
Cobis A/S
![]() Cobis A/S Miscellaneous Commercial ServicesCommercial Services Cobis A/S provides business support services. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
University of Copenhagen | College/University | Corporate Officer/Principal | |
Symbion A/S
![]() Symbion A/S General GovernmentGovernment Symbion A/S provides office communities, meeting facilities, conference facilities, business development and capital for start-up companies. The company was founded in 1986 and is headquartered in Copenhagen, Denmark. | General Government | Corporate Officer/Principal | |
Mobidiag Oy
![]() Mobidiag Oy Miscellaneous Commercial ServicesCommercial Services Mobidiag Oy provides molecular diagnostic for infectious diseases. It develops and provides microarray-based Prove-it technology for early and diagnosis of life-threatening pathogenic microbes causing severe infections. Its Amplidiag product line comprises products for gastrointestinal pathogens and utilizes quantitative real-time polymerase chain reaction technology. The company was founded by Mart Saarma in 2000 and is headquartered in Espoo, Finland. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Copenhagen Business Center | Corporate Officer/Principal | ||
Renovaro Biosciences Denmark ApS
![]() Renovaro Biosciences Denmark ApS Miscellaneous Commercial ServicesCommercial Services Dandrit Biotech A/S conducts clinical research, trading, and manufacturing for the pharmaceutical industry. It focuses on research and development of medicines. The company was founded on April 1, 2001 and is headquartered in Hørsholm, Denmark. | Miscellaneous Commercial Services | Chief Executive Officer | |
OncoNOx ApS
![]() OncoNOx ApS Pharmaceuticals: MajorHealth Technology OncoNOx ApS provides drugs for the treatment of autoimmune diseases and cancer. It is a pharmaceutical company that transforms marketed drugs into proprietary molecules with anti-cancer and/or anti-inflammatory properties. The firm's projects include OX1001 and OX27-NO is a potent anti-cancer compounds in vitro and in vivo and are intended for the treatment of cancer, and OX1001 also exhibits anti-viral activity and is in development for treatment of human immunodeficiency virus (HIV) and acquired immune deficiency syndrome patients with or without HIV related cancer. The company was founded by Ferdinando Nicoletti, Gianni Garotta, Yousef Al-Abed, Marco Donia, and Mai-Britt Zocca in 2011 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Founder | |
CIRCIO HOLDING ASA | Biotechnology | Corporate Officer/Principal | |
HERANTIS PHARMA OYJ | Pharmaceuticals: Major | Chief Executive Officer | |
Aalto University School of Science & Technology | College/University | Doctorate Degree | |
Optomed Software Oy
![]() Optomed Software Oy Packaged SoftwareTechnology Services Optomed Software Oy develops and sells proprietary software solutions for healthcare organizations. It offers products for workflow, resource and quality management within radiological or surgical departments or any screening or follow-up program. The company was founded in 1989 and is headquartered in Espoo, Finland. | Packaged Software | Director/Board Member | |
Neumirna Therapeutics ApS | Biotechnology | Director/Board Member | |
NORDION INC | Pharmaceuticals: Major | Corporate Officer/Principal | |
International Institute for Management Development | College/University | Masters Business Admin | |
Cita NeuroPharmaceuticals, Inc.
![]() Cita NeuroPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cita Neuro Pharmaceuticals, Inc. develops and commercializes small molecule drugs. Its clinical drug portfolio consists of drugs for Parkinson's disease and neuropathic pain. Cita Neuro Pharmaceuticals was founded in 1997 by Brian Bennett, Roland Boegman, Khem Jha-mandas, James Reynolds and Gregory Thatcher and is headquartered in Mississauga, Canada. | Pharmaceuticals: Major | Chief Executive Officer | |
Teitur Trophics ApS
![]() Teitur Trophics ApS BiotechnologyHealth Technology Teitur Trophics ApS develops novel treatments. The company is based in Aarhus, Denmark. The Danish company was founded by Simon Mølgaard, Mathias Kaas Ollendorff, Anders Dalby, Simon Glerup. Simon Mølgaard has been the CEO since incorporation. | Biotechnology | Director/Board Member | |
Suomen Bioteollisuus ry | Director/Board Member | ||
Helsinki Innovation Services Ltd.
![]() Helsinki Innovation Services Ltd. Miscellaneous Commercial ServicesCommercial Services Part of University of Helsinki, Helsinki Innovation Services Ltd. is a company that provides business and innovation-related consulting services. The company is based in Helsinki, Finland. | Miscellaneous Commercial Services | Chief Operating Officer | |
Innovestor Ventures Oy
![]() Innovestor Ventures Oy Investment ManagersFinance Innovestor Ventures Oy is a venture capital firm, a subsidiary of Innovestor Oy founded in 2014. The firm is headquartered in Helsinki, Finland. | Investment Managers | Private Equity Investor | |
Neurotrophic Bioscience, Inc.
![]() Neurotrophic Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Neurotrophic Bioscience, Inc. develops pharmaceutical products. | Pharmaceuticals: Major | President | |
Tribune Therapeutics AB
![]() Tribune Therapeutics AB Miscellaneous Commercial ServicesCommercial Services Tribune Therapeutics AB is a preclinical biopharmaceutical company that focuses on developing novel medicines to treat patients with fibrotic diseases. Healthcap and Novo Seeds provided funding for the company, and they are based in Stockholm, Sweden. The Swedish company was created by Healthcap and Novo Seeds, the early-stage investment and company creation team of Novo Holdings. The company was founded in 2020 and has in-licensed an asset from one of the largest technology transfer offices in the Nordic region. The founders of the company are Håvard Attramadal, Ole J. Kaasbøll, and Georg Vo Beiske, who has been the CEO since 2020. | Miscellaneous Commercial Services | Director/Board Member | |
University of Eastern Finland | College/University | Undergraduate Degree | |
Innovestor Oy
![]() Innovestor Oy Investment ManagersFinance Innovestor Oy is a venture and growth equity firm headquartered in Helsinki, Finland. The firm was founded by Tommi Äijälä and Antti Parviainen in 2014. | Investment Managers | Private Equity Investor | |
Aranda Pharma Oy
![]() Aranda Pharma Oy BiotechnologyHealth Technology Aranda Pharma Ltd. engages in the research and development of novel small molecules to combat prostate cancer and neurodegenerative diseases. The company was founded by Anu Muona, Milla Koistinaho, Jari Koistinaho, and Gundars Goldsteins in September 2015 and is headquartered in Kuopio, Finland. | Biotechnology | Founder |
Statistik
International
Finnland | 18 |
Dänemark | 14 |
Australien | 8 |
Deutschland | 4 |
Vereinigtes Königreich | 4 |
Sektoral
Health Technology | 17 |
Commercial Services | 13 |
Consumer Services | 7 |
Technology Services | 4 |
Finance | 3 |
Operativ
Director/Board Member | 25 |
Corporate Officer/Principal | 17 |
Chief Executive Officer | 15 |
President | 9 |
Chairman | 6 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Paul Anthony Porter
- Unternehmensverbindungen